Back to results
US 2019/0338043 A1Published application
Novel Anti-Human Transferrin Receptor Antibody Capable of Penetrating Blood-Brain Barrier
AssigneeJCR Pharmaceuticals Co., Ltd.
InventorsHiroyuki Sonoda, Kenichi Takahashi
Life of this patent
Estimating the term…
Abstract
Provided is an anti-human transferrin receptor antibody or an analog thereof, wherein in the heavy chain variable region of the antibody, (a) CDR1 comprises the amino acid sequence set forth as SEQ ID NO: 62 or SEQ ID NO: 63, (b) CDR2 comprises the amino acid sequence set forth as SEQ ID NO: 13 or SEQ ID NO: 14, and (c) CDR3 comprises the amino acid sequence set forth as SEQ ID NO: 15 or SEQ ID NO: 16, and an analogue thereof.
Claims74
An anti-human transferrin receptor antibody, wherein in the heavy chain variable region of the antibody,
- (a) CDR1 comprises the amino acid sequence set forth as SEQ ID NO:
- 62 or SEQ ID NO:
- 63,
- (b) CDR2 comprises the amino acid sequence set forth as SEQ ID NO:
- 13 or SEQ ID NO:
- 14, and
- (c) CDR3 comprises the amino acid sequence set forth as SEQ ID NO:
- 15 or SEQ ID NO:
- 16.
6 more elements
71-72. (canceled)
74-78. (canceled)
Dependencies are inferred from the claim text.